Loading stock analysis…
Evidence Synthesis
Last synthesized: 22 Aug 2026, 00:09
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
AARTIDRUGS Posts Strong Quarterly Results The company's 37.53% gross margin accelerated, up from 11.45% in the previous quarter.
Revenue growth accelerated, with a increase, while marginal operating leverage also rose, to . The stock's close price accelerated, rising by INR to INR.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 37.53 % | 11.45 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 11.45 % | 7.14 | ▲ |
| REVENUE_GROWTH_YOY | 19.1 % | -7.1 | ▲ |
| EPS_ACTUAL | 4.95 INR | 5.663 | ▼ |
| EPS_SURPRISE_PERCENT | 0.01 % | 0.049 | ▼ |
| PRICE_CHANGE_PERCENT | 0.639 % | — | - |
| DAILY_VOLUME | 1,71,529 shares | 1,98,279 | ▼ |
| CLOSE_PRICE | 417.4 INR | 414.75 | ▲ |
| NEWS_SENTIMENT_SCORE | 1 score | — | - |
| ANALYST_STRONG_BUY_COUNT | 1 count | 0 | ▲ |
| TARGET_PRICE_PREMIUM | 13.56 % | — | - |